Dr Jacques Mallet, former SVP of Portfolio Analytics/Corporate Strategy at Sanofi, joins NEUWAY's Advisory Board as independent member adding in depth expertise in pharma corporate development,
Dr Jacques Mallet, former SVP of Portfolio Analytics/Corporate Strategy at Sanofi, joins NEUWAY’s Advisory Board as independent member adding in depth expertise in pharma corporate development, financing and clinical affairsBONN, Germany (BUSINESS WIRE) #biotechnology NEUWAY Pharma GmbH, « NEUWAY », a preclinical.
/PRNewswire/ Vade, an international pioneer in threat detection and response that already monitors one billion email messages worldwide, has announced that.
Lyon, 13 January 2022 - Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development of drug candidates modulating the interaction
Dr Robert L. Coleman, Chief Scientific Officer of US Oncology Network and Dr Jacques Mallet, former SVP Portfolio Analytics/Corporate Strategy at Sanofi, join the Company's Board as independent members Regulatory